Technologies

1. Features of the Glycan-Recognition Device GlycoCapture®

In genomic medicine, it is essential to detect target genomes with high sensitivity and specificity. To achieve this, technologies capable of disease-specific capture and enrichment of exosomes and other vesicles containing the target genome are required.
At The IT Lab, we focused on cancer-specific glycans as unique molecular markers. By targeting these glycans, we have developed a technology that enables highly specific capture and enrichment of exosomes, leading to highly sensitive detection.

GlycoCapture🄬 is an innovative device that targets cancer-specific glycans to selectively and sensitively capture and enrich exosomes derived from cancer cells.

Basic Research Data

Results of EV Capture Using Human Cancer Cells

Silica monolith-based spin column with high-density, highly oriented OAA immobilization
→Achieved more efficient EV capture compared to commercial